Cancer Communications
indexed by SCI
BMC


ORIGINAL ARTICLE
Co-occurrence of germline pathogenic variants for different hereditary cancer syndromes in patients with Lynch syndrome
Rosario Ferrer-Avargues, María Isabel Castillejo, Estela Dámaso, Virginia Díez-Obrero, Noemí Garrigos, Tatiana Molina, Alan Codo?er-Alejos, ángel Segura, Ana Beatriz Sánchez-Heras, Adela Castillejo, José Luis Soto
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/25/2021   doi:10.1002/cac2.12134
LETTER TO THE EDITOR
Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis
Jun Ho Yi, Seok Jin Kim, Dok Hyun Yoon, Cheolwon Suh, Myung Hee Chang, Deok Hwan Yang, Jae‐Cheol Jo, Shin Young Hyun, Hyeon‐Seok Eom, Jeong‐Ok Lee, Ji Hyun Kwon, Sang Hoon Han, Seung‐Shin Lee, Jae‐Yong Kwak, Se Hyung Kim, Dae Sik Kim, Ji Hyun Lee, Sung Yong Oh, Hun Mo Ryoo, Hyo Jung Kim, Won Seog Kim
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/24/2021   doi:10.1002/cac2.12150
LETTER TO THE EDITOR
Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending
Tao Huang, Anita Katharina Wagner, Lin Bai, Cong Huang, Xiaodong Guan, Luwen Shi
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/20/2021   doi:10.1002/cac2.12144
ORIGINAL ARTICLE
Impact of diabetes on promoting the growth of breast cancer
Ping-Chieh Chou, Hyun Ho Choi, Yizhi Huang, Enrique Fuentes-Mattei, Guermarie Velazquez-Torres, Fanmao Zhang, Liem Phan, Jaehyuk Lee, Yanxia Shi, James A Bankson, Yun Wu, Huamin Wang, Ruiying Zhao, Sai-Ching Jim Yeung, Mong-Hong Lee
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/20/2021   doi:10.1002/cac2.12147
REVIEW
Involvement of long non‐coding RNAs in the progression of esophageal cancer
Wenhua Xue, Yuanyuan Zheng, Zhibo Shen, Lifeng Li, Zhirui Fan, Wenbin Wang, Zijia Zhu, Yunkai Zhai, Jie Zhao, Quancheng Kan
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/19/2021   doi:10.1002/cac2.12146
RESEARCH HIGHLIGHT
Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high‐risk T‐cell lymphoblastic lymphoma?
Ken H. Young
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/19/2021   doi:10.1002/cac2.12148
ORIGINAL ARTICLE
Junction plakoglobin regulates and destabilizes HIF2α to inhibit tumorigenesis of renal cell carcinoma
Ke Chen, Jin Zeng, Yi Sun, Wei Ouyang, Gan Yu, Hui Zhou, Yangjun Zhang, Weimin Yao, Wei Xiao, Junhui Hu, Jinchun Xing, Kefeng Xiao, Lily Wu, Zhiqiang Chen, Zhangqun Ye, Hua Xu
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/16/2021   doi:10.1002/cac2.12142
ORIGINAL ARTICLE
Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4
Ting Guo, Yan-Hua Bai, Xiao-Jing Cheng, Hai-Bo Han, Hong Du, Ying Hu, Shu-Qin Jia, Xiao-Fang Xing, Jia-Fu Ji
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/11/2021   doi:10.1002/cac2.12141
ORIGINAL ARTICLE
Pre‐transplantation cytoreduction does not benefit advanced myelodysplastic syndrome patients after myeloablative transplantation with grafts from family donors
Yu-Qian Sun, Lan-Ping Xu, Kai-Yan Liu, Xiao-Hui Zhang, Chen-Hua Yan, Jian Jin, Xiao-Jun Huang, Yu Wang
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/10/2021   doi:10.1002/cac2.12140
ORIGINAL ARTICLE
Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2‐positive breast cancer: An open‐label, dose‐escalation, phase I study
Ruoxi Hong, Wen Xia, Liye Wang, Kaping Lee, Qianyi Lu, Kuikui Jiang, Shengfeng Li, Jinquan Yu, Jin Wei, Weijia Tang, Danyang Zhou, Xin An, Jiajia Huang, Cong Xue, Xiwen Bi, Yanxia Shi, Zhongyu Yuan, Fei Xu, Shusen Wang
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/2/2021   doi:10.1002/cac2.12135

<<    Page 2 of 36  >>    




CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China